Trial Profile
A real-world clinical observation: the quality of life and safety of sacubitril/valsartan in chronic Heart Failure patients with reduced ejection fraction
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Apr 2018
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- 25 Apr 2018 New trial record